Search
for
Sort by
Research 61–90 of 1000+
- Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata
- JAK-inhibitors in the therapy of comorbid diseases – atopic dermatitis and alopecia areata: literature review and experience of clinical practice
- Treatment of alopecia areata with JAK inhibitors: a review of the literature
- El papel de los inhibidores de JAK en la alopecia areata: revisión de la literatura
- Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis
- Safety of oral JAK inhibitors in treating alopecia areata: a systematic review and network meta-analysis
- Janus Kinase inhibitors in dermatology: a review
- The development of oral hairy leukoplakia during JAK inhibitor baricitinib therapy
- Turning JAK STATic, a peek into the future of dermatology therapeutics
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- Irish dermatologists’ experience with JAK inhibitors in alopecia areata
- BH19 ‘JAK in the box?’ Long-term safety concerns with oral Janus kinase inhibitors for alopecia areata
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- JAK inhibitors in dermatology: The promise of a new drug class
- Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
- Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis
- JAK Inhibitors for Treatment of Alopecia Areata
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- Small Molecule Inhibitors and Inflammatory Skin Diseases
- Under Development JAK Inhibitors for Dermatologic Diseases
- Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis
- Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
- The Role of Janus Kinase Inhibitors in Dermatology
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- Efficacy and Tolerability of Brevilin-A, a Natural JAK Inhibitor, in Pediatric Alopecia Areata: A Case Series
- Alopecia Universalis Treated With Tofacitinib: The Role of JAK/STAT Inhibitors in Hair Regrowth